← Back to Search

Physical Activity Program for Breast Cancer (MFT4 Trial)

N/A

Waitlist Available

Led By Bernardine M. Pinto, PhD

Research Sponsored by University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ambulatory

Able to walk unassisted

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month intervention

Awards & highlights

MFT4 Trial Summary

This trialwill measure effects of a 3-month physical activity intervention on breast cancer survivors not currently active. A web-based platform and virtual calls with a peer coach will be used to increase activity. Participants will be given a Fitbit to monitor activity.

Who is the study for?

This trial is for breast cancer survivors diagnosed within the last 5 years, who are currently inactive. They should be able to walk unassisted, read and speak English, and have access to a smartphone with Bluetooth and internet. Participants must not engage in more than 30 minutes of vigorous or 90 minutes of moderate-intensity physical activity weekly.Check my eligibility

What is being tested?

The study tests if guidance from a peer coach can help increase moderate-intensity physical activity over three months compared to self-monitoring. Participants will be randomly placed into two groups: one receiving weekly virtual coaching and the other monitoring their own activity levels. Both groups get a Fitbit.See study design

What are the potential side effects?

Since this trial involves increasing physical activity, potential side effects may include muscle soreness, fatigue, or injury due to exercise. However, these risks are generally low as activities are moderate in intensity.

MFT4 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can walk on my own without help.

Select...

I can walk by myself without help.

Select...

I was diagnosed with Stage 0-3 breast cancer in the last 5 years.

MFT4 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Accelerometer measured moderate-to-vigorous activity

Secondary outcome measures

Self-Reported Fatigue

Self-Reported Mood

Self-Reported Physical Functioning

+1 more

MFT4 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: webMFTExperimental Treatment1 Intervention

Survivors randomized to webMFT will receive the evidence-based intervention for moderate-to-vigorous physical activity (MVPA) promotion that consists of MVPA counseling matched to patients' motivational readiness, and self-monitoring of MVPA (via Fitbit Inspire 2). The goal for the 3-month program will be to gradually increase the amount of moderate-intensity aerobic exercise that is performed, to the current national recommendations of at least 150 minutes of MPVA per week. Our goal is to promote aerobic exercise that is safe and enjoyable, such as walking.

Group II: MVPA trackingActive Control1 Intervention

These survivors will be asked to self-monitor moderate-to-vigorous physical activity (MVPA) participation by wearing the Fitbit Inspire 2 each day over 12 weeks. This group will not receive the MVPA counseling from the coaches.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Colorado, DenverOTHER

1,732 Previous Clinical Trials

2,143,515 Total Patients Enrolled

26 Trials studying Breast Cancer

6,445 Patients Enrolled for Breast Cancer

University of South CarolinaLead Sponsor

211 Previous Clinical Trials

120,391 Total Patients Enrolled

4 Trials studying Breast Cancer

763 Patients Enrolled for Breast Cancer

InquisitHealth, Inc.OTHER

2 Previous Clinical Trials

336 Total Patients Enrolled

Media Library

Physical activity adoption Clinical Trial Eligibility Overview. Trial Name: NCT05409664 — N/A

Breast Cancer Research Study Groups: MVPA tracking, webMFT

Breast Cancer Clinical Trial 2023: Physical activity adoption Highlights & Side Effects. Trial Name: NCT05409664 — N/A

Physical activity adoption 2023 Treatment Timeline for Medical Study. Trial Name: NCT05409664 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been enrolled in this research endeavor?

"Affirmative, clinicaltrials.gov provides evidence that this medical research is actively seeking patients for enrolment. It was posted on November 1st 2022 and most recently updated on December 15th 2022; 68 participants need to be recruited from a single site."

Answered by AI

Are there any vacancies available within this clinical trial?

"Affirmative. The clinicaltrials.gov website suggests that this research effort is currently recruiting for 68 participants from a single site. This trial was initially posted on November 1st 2022, with the latest update taking place on December 15th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Moving Forward Together 4

Bernardine Pinto 2022. "Moving Forward Together 4". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05409664.

All > Breast Cancer Columbia